sc-479

antibody from Santa Cruz Biotechnology

Targeting: FLT3 CD135, FLK2, STK1

Immunohistochemistry (Supportive data in Antibodypedia)

Antibody Data

Product number

sc-479

Provider

Santa Cruz Biotechnology

Proper citation

Santa Cruz Biotechnology Cat#sc-479, RRID:AB_631052

Product name

Anti-FLT3

Antibody type

Polyclonal (Antigen purified)

Antigen

Synthetic peptide

Reactivity

Human

Host

Rabbit

References

Submitted references

Dasatinib inhibits the growth of molecularly heterogeneous myeloid leukemias.

Guerrouahen BS, Futami M, Vaklavas C, Kanerva J, Whichard ZL, Nwawka K, Blanchard EG, Lee FY, Robinson LJ, Arceci R, Kornblau SM, Wieder E, Cayre YE, Corey SJ
Clinical cancer research : an official journal of the American Association for Cancer Research 2010 Feb 15;16(4):1149-58

---

FLT3 internal tandem duplication mutations induce myeloproliferative or lymphoid disease in a transgenic mouse model

Benjamin H Lee, Ifor R Williams, Ema Anastasiadou, Christina L Boulton, Sarah W Joseph, Sonia M Amaral, David P Curley, Nicole Duclos, Brian J P Huntly, Doriano Fabbro, James D Griffin, Dwight Gary Gilliland
Oncogene 2005 Aug;24(53):7882-7892

Immunohistochemistry

Supportive validation

Submitted by

per

Main image

Experimental details

Immunohistochemical staining of human malignant lymphoma shows granular cytoplasmic positivity in tumor cells.

Validation comment

No experimental and/or bioinformatic data available, or staining pattern not consistent with experimental and/or bioinformatic data.